240 likes | 445 Views
IMMUNIZATIONS, PART I. Janine Clark Adjo, M.D. 2010 IMMUNIZATION SCHEDULE. DTaP (IM). Diptheria and Tetanus components are bacterial toxoids (modified bacterial toxin that has been made nontoxic but retains ability to stimulate antibody production)
E N D
IMMUNIZATIONS, PART I Janine Clark Adjo, M.D.
DTaP (IM) • Diptheria and Tetanus components are bacterial toxoids (modified bacterial toxin that has been made nontoxic but retains ability to stimulate antibody production) • Acellular pertusis- inactivated acellular bacterial components
DTaP • DTaP- for use in children <7 • DT- for use in children <7, in whom pertussis vaccine is contraindicated • Dt- Tetanus toxoid, with 1/3- 1/6 the dose of diptheria toxoid, for use >7 • DTP- whole cell pertussis no longer marketed in US
DTaPINDICATIONS • Routine schedule- 2 mths, 4mths, 6mth, 15-18 mths, followed by Tdap at 11/12 years and then every 10 years • Unimmunized pregnant women • Tetanus prophylaxis, wound management
DTaPTrue Contraindications • Anaphylaxis to vaccine or constituent of vaccine • Encephalopathy within 7 days of receiving vaccine, then use DT for remaining doses
DTaPPRECAUTIONS • Moderate or severe illness regardless of fever • Seizure within 3 days of administration • Persistent crying within 48 hours of prior dose • Collapse or hypotonic/hyporesponsive episode within 48 hours of prior dose • Neurologic disorders
DTaPSIDE EFFECTS • Erythema, swelling, pain, fever, irritability • Anaphylaxis • Seizure • Hyporesponsive/hypotonic episode • Persistent crying • Fever >105
DTaPDifferent Formularies • Daptacel- Sanofi Pasteur • Tripedia- Sanofi Pasteur • Infanrix- GlaxoSmithKline • DT- Sanofi Pasteur • Td- Decavac- Sanofi Pasteur • Adacel/Boostrix- Tdap- Sanofi Pasteur/GSK
DTaPDifferent formularies • TriHIBit- Sanofi Pasteur • Pediarix- GSK • Pentacel- Sanofi Pasteur • Kinrix- GSK
Haemophilus Influenza Type BHib (IM) • Conjugate vaccine of Hib capsular polysaccharide antigen and a carrier protein to enhance immunogenicity • Two types 1) PRP+CRM- given at 2,4,6, and 12-15 months 2) PRP+OMP- given at 2, 4 , 12-15 months
HiB • Routine vaccination has led to a 99% decrease in invasive Hib disease • Schedule for unimmunized children 1)7-11 months: 3 doses, 2 months apart 2)12-14 months: 2 doses 2 months apart 3)15-59 months: 1 dose 4) >5 does not require immunization
HiBSide Effects/Contraindications • Local pain, erythema, swelling, fever, irritability • Anaphylaxis
HiBDifferent Formularies • HiB, HbOC, conjugate, 4 dose- Hib titer, Wyeth • HiB, PRP-OMP, conjugate, 3 dose- pedvaxHiB, Merck • HiB, PRPT, conjugate, 4 dose, ActHiB, Sanofi Pasteur • DTaP-HiB, TriHiBit, Sanofi Pasteur • Hep B/Hib- Comvax, Merck
Hepatitis B (IM) • Inactivated viral antigen • Required for middle school entry in 1998 • Routine schedule 0-2 months, 1-4 months, 6-18 months • Dose 3 cannot be given prior to 6 months
Hepatitis BSide Effects/Contraindications • Pain at site, fever • Anaphylaxis to vaccine or Baker’s yeast
Hepatitis BDifferent Formularies • Hepatitis B, Recombivax, Merck • Hepatitis B, Energix- B, GSK • Hep B/Hib, Comvax, Merck
POLIO (SC or IM) • IPV- trivalent vaccine of inactivated polio virus types 1, 2, and 3, grown in human diploid cells • Routine schedule- 2 mths, 4 mths, 6 mths, 4-6 years
POLIOSide effects/Contraindications • Pain, swelling and erythema at site • Anaphylaxis to vaccine, polymyxin B, neomycin, or streptomycin
POLIODifferent Formularies • IPV, IPOL, Sanofi Pasteur • Pentacel, Sanofi Pasteur • Pediarix, GSK
Pneumococcal Vaccine (IM) • Prevnar 13- Pneumococcal Conjugate vaccine comprised of 13 capsular polysaccharides of Streptococcus pneumoniae • Routine schedule 2mths, 4 mths, 6mths, 12-15 mths
PrevnarSide effects/Contraindications • Pain, swelling, and erythema at site of injection • Fever, irritability, decreased appetite • Anaphylaxis to vaccine
PrevnarDifferent Formularies • Prevnar, Wyeth
Pneumococcal vaacine Different Formularies • Pneumovax (IM or SC)- pneumococcal polysaccharide vaccine, 23 valent, Merck • Ages 2 and up • Immunosuppressed patients